glp 1 in heart failure GLP-1 receptor agonists and myocardial metabolism atrial fibrillation GLP-1 Agonists in Cardiovascular Diseases:

A meta-analysis which included eight trials with a total of 60,080 patients found that GLP-1 agonists reduced major adverse cardiovascular events, all-cause mortality and hospital admissions for heart failure in treated patients with type 2 diabetes, regardless of structural homology 20

Interventions aimed at regulating oxidative stress, restoring antioxidant defenses, chelating iron, and preventing lipid peroxidation are at the forefront of these efforts ( Figure 6 )

4 June 2021

12 Creatine supplementation increases the rate of phosphocreatine synthesis during recovery periods

& Allegretti, J

Here the evidence is notably weaker